Improving the in-vivo biological activity of fingolimod loaded PHBV nanoparticles by using hydrophobically modified alginate-Reference-Cited by-同舟云学术

Improving the in-vivo biological activity of fingolimod loaded PHBV nanoparticles by using hydrophobically modified alginate

Published:2020-02-01 Issue:2 Volume:46 Page:318-328
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Rezaie Shirmard Leila¹,Ghofrani Mahdieh²,Bahari Javan Nika²,Bayrami Samane²,Tavassoli Abdollah³,Rezaie Amir⁴,Amini Mohsen⁵⁶,Kebriaee-zadeh Abbas⁷,Rouini Mohammad-Reza⁸,Dinarvand Rassoul²^ORCID,Rafiee-Tehrani Morteza²,Dorkoosh Farid Abedin²⁹

Affiliation:

1. Department of Pharmaceutics, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran;

2. Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran;

3. Department of Analytical chemistry, University of Mazandaran, Babolsar, Iran;

4. School of Dentistry, Ardabil University of Medical Sciences, Ardabil, Iran;

5. Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran;

6. Drug Design and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran;

7. Department of Pharmacoeconomy and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran;

8. Biopharmaceutics and Pharmacokinetic Division, Department of Pharmaceutics, Faculty of Pharmacy, University of Medical Sciences, Tehran, Iran;

9. Medical Biomaterial Research Centre (MBRC), Tehran University of Medical Sciences, Tehran, Iran

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2020.1721524

Reference59 articles.

1. FTY720, A Novel Immunomodulator: Efficacy and Safety Results from the First Phase 2A Study in de novo Renal Transplantation

2. Multiple-Dose FTY720: Tolerability, Pharmacokinetics, and Lymphocyte Responses in Healthy Subjects

3. FTY720: Placebo-Controlled Study of the Effect on Cardiac Rate and Rhythm in Healthy Subjects

4. Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study

5. Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery;Advanced Drug Delivery Reviews;2024-03

2. Tuning Material Properties of Microbially Synthesized Poly(3-hydroxybutyrate-co-hydroxyvalerate) and Their Composites for Various Applications;Journal of Polymers and the Environment;2023-05-27

3. Role of nanotechnology in the prolonged release of drugs by the subcutaneous route;Expert Opinion on Drug Delivery;2023-05-04

4. CDX-modified chitosan nanoparticles remarkably reduce therapeutic dose of fingolimod in the EAE model of mice;International Journal of Pharmaceutics;2023-04

5. Experimental and Theoretical Investigation of Inclusion Complexes of β-Cyclodextrin with Fingolimod;Russian Journal of Physical Chemistry A;2023-03